Pfizer’s COVID revenues have dropped off along with attention to the pandemic
January 31, 2023 at 13:16 PM EST
Wall Street urged Pfizer to lower its COVID revenue estimates. The company did — but it's still betting on higher demand for its vaccine and antiviral by 2025.